Merck & Co. is a global biopharmaceutical company based in New Jersey that discovers, develops, and markets medicines and vaccines to treat cancer, infectious diseases, autoimmune disorders, and other conditions. The company maintains a strong cancer portfolio anchored by an immuno-oncology therapy platform led by Keytruda and a growing vaccine business including Gardasil for human papillomavirus. Its research arm, Merck Research Laboratories, focuses on discovering and developing therapies for cancer and neurodegenerative diseases. Merck also markets animal health products. Through its science-driven approach, Merck aims to deliver innovative products and therapies that improve patient outcomes worldwide.
SAB Biotherapeutics is a clinical-stage biopharmaceutical company established in 2014, headquartered in Sioux Falls, South Dakota with additional offices in Cambridge, Massachusetts. The company specializes in developing immunotherapies using its proprietary DiversitAb platform, which employs transchromosomic cattle to produce large quantities of targeted human polyclonal antibodies without relying on human plasma or serum. SAB's pipeline includes therapies for conditions such as Type 1 diabetes (SAB-142), seasonal influenza (SAB-176), and Middle East Respiratory Syndrome Coronavirus (MERS-CoV, SAB-301).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.